BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rampal R, Kedia S, Wari MN, Madhu D, Singh AK, Tiwari V, Mouli VP, Mohta S, Makharia G, Ahuja V. Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease. Intest Res 2021;19:232-8. [PMID: 32375209 DOI: 10.5217/ir.2019.09181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Cao T, Dai G, Chu H, Kong C, Duan H, Tian N, Sun Z. Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients. Hereditas 2022;159. [DOI: 10.1186/s41065-022-00219-y] [Reference Citation Analysis]
2 Kedia S, Ahuja V. Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion. JGH Open 2021;5:177-9. [PMID: 33553652 DOI: 10.1002/jgh3.12495] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim JM, Kang JG, Kim S, Cheon JH. Deep-learning system for real-time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis. J Gastroenterol Hepatol 2021;36:2141-8. [PMID: 33554375 DOI: 10.1111/jgh.15433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jiang H, Cui B, Zhang J. Mycobacterium tuberculosis (MTB) antigen-induced upregulation of interleukin-35 expression in patients with MTB infection: In vitro blockade of the effects of interleukin-35 on T lymphocyte subsets. Pathog Dis 2021;79:ftab035. [PMID: 34245560 DOI: 10.1093/femspd/ftab035] [Reference Citation Analysis]
5 Maulahela H, Simadibrata M, Nelwan EJ, Rahadiani N, Renesteen E, Suwarti SWT, Anggraini YW. Recent advances in the diagnosis of intestinal tuberculosis. BMC Gastroenterol 2022;22:89. [PMID: 35227196 DOI: 10.1186/s12876-022-02171-7] [Reference Citation Analysis]